The global market for peripheral neuropathy comprises the manufacture of products and therapies used to diagnose, treat and manage this disease, which affects the peripheral nerves. This market comprises of solutions including drugs, equipment like pacemakers and biologics, and innovative solutions including cell growth technologies and neural regeneration systems. Peripheral neuropathy is caused by factors like diabetes, infections, autoimmune diseases and trauma and can manifest as pain, tingling or weakness in an affected part of the body. Rising incidences of disease that lead to peripheral neuropathy globally the industry is propelled by advancing awareness, innovative solutions, and the need for effective therapies.

The peripherally inserted central catheters (PICC) market encompasses centrally inserted long-term vascular access devices used for administering medicines, nutrients or fluids in the patient’s peripheral veins. PICCs are long, thin, flexible tubes inserted through one of the peripheral veins of the commonly exercised areas of the arm then threaded to a large central vein, near the heart.